1-13 of 13
Sufi M. Thomas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Free
Neil D. Gross, Julie E. Bauman, William E. Gooding, William Denq, Sufi M. Thomas, Lin Wang, Simion Chiosea, Brian L. Hood, Melanie S. Flint, Mai Sun, Thomas P. Conrads, Robert L. Ferris, Jonas T. Johnson, Seungwon Kim, Athanassios Argiris, Lori Wirth, Marina N. Nikiforova, Jill M. Siegfried, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (12): 3289–3298.
https://doi.org/10.1158/1078-0432.CCR-13-3360
Published: 12 June 2014
View articletitled, Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer
Open the PDF for Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical Studies

Free
Dong M. Shin, Hongzheng Zhang, Nabil F. Saba, Amy Y. Chen, Sreenivas Nannapaneni, A.R.M. Ruhul Amin, Susan Müller, Melinda Lewis, Gabriel Sica, Scott Kono, Johann C. Brandes, William J. Grist, Rachel Moreno-Williams, Jonathan J. Beitler, Sufi M. Thomas, Zhengjia Chen, Hyung Ju C. Shin, Jennifer R. Grandis, Fadlo R. Khuri, Zhuo Georgia Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (5): 1244–1256.
https://doi.org/10.1158/1078-0432.CCR-12-3149
Published: 03 March 2013
View articletitled, Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical Studies
Open the PDF for Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical Studies in another window
Includes: Supplementary data
Journal Articles

c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met

Free
Laura P. Stabile, Guoqing He, Vivian Wai Yan Lui, Sufi M. Thomas, Cassandra Henry, Christopher T. Gubish, Sonali Joyce, Kelly M. Quesnelle, Jill M. Siegfried, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (2): 380–392.
https://doi.org/10.1158/1078-0432.CCR-12-1555
Published: 16 January 2013
View articletitled, c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met
Open the PDF for c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met in another window
Includes: Supplementary data
Journal Articles

Carfilzomib and ONX 0912 Inhibit Cell Survival and Tumor Growth of Head and Neck Cancer and Their Activities Are Enhanced by Suppression of Mcl-1 or Autophagy

Free
Yan Zang, Sufi M. Thomas, Elena T. Chan, Christopher J. Kirk, Maria L. Freilino, Hannah M. DeLancey, Jennifer R. Grandis, Changyou Li, Daniel E. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (20): 5639–5649.
https://doi.org/10.1158/1078-0432.CCR-12-1213
Published: 14 October 2012
View articletitled, Carfilzomib and ONX 0912 Inhibit Cell Survival and Tumor Growth of Head and Neck Cancer and Their Activities Are Enhanced by Suppression of Mcl-1 or Autophagy
Open the PDF for Carfilzomib and ONX 0912 Inhibit Cell Survival and Tumor Growth of Head and Neck Cancer and Their Activities Are Enhanced by Suppression of Mcl-1 or Autophagy in another window
Includes: Supplementary data
Journal Articles

Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer

Free
Malabika Sen, Sonali Joyce, Mary Panahandeh, Changyou Li, Sufi M. Thomas, Jessica Maxwell, Lin Wang, William E. Gooding, Daniel E. Johnson, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (18): 4986–4996.
https://doi.org/10.1158/1078-0432.CCR-12-0792
Published: 16 September 2012
View articletitled, Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
Open the PDF for Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer in another window
Includes: Supplementary data
Journal Articles

Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to Cetuximab

Free
Neil E. Bhola, Sufi M. Thomas, Maria Freilino, Sonali Joyce, Anirban Sahu, Jessica Maxwell, Athanassios Argiris, Raja Seethala, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (15): 4996–5004.
https://doi.org/10.1158/1078-0432.CCR-10-3406
Published: 31 July 2011
View articletitled, Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to Cetuximab
Open the PDF for Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to Cetuximab in another window
Includes: Supplementary data
Journal Articles

Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors

Free
Rebecca J. Leeman-Neill, Quan Cai, Sonali C. Joyce, Sufi M. Thomas, Neil E. Bhola, Daniel B. Neill, Jack L. Arbiser, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (9): 2571–2579.
https://doi.org/10.1158/1078-0432.CCR-10-0333
Published: 28 April 2010
View articletitled, Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors
Open the PDF for Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors in another window
Journal Articles

HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer

Free
Lynn M. Knowles, Laura P. Stabile, Ann Marie Egloff, Mary E. Rothstein, Sufi M. Thomas, Christopher T. Gubish, Edwina C. Lerner, Raja R. Seethala, Shinsuke Suzuki, Kelly M. Quesnelle, Sarah Morgan, Robert L. Ferris, Jennifer R. Grandis, Jill M. Siegfried
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (11): 3740–3750.
https://doi.org/10.1158/1078-0432.CCR-08-3252
Published: 01 June 2009
View articletitled, HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer
Open the PDF for HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer in another window
Includes: Supplementary data
Journal Articles

Combined Inhibition of PLCγ-1 and c-Src Abrogates Epidermal Growth Factor Receptor–Mediated Head and Neck Squamous Cell Carcinoma Invasion

Free
Hiroshi Nozawa, Gina Howell, Shinsuke Suzuki, Qing Zhang, Yanjun Qi, Judith Klein-Seetharaman, Alan Wells, Jennifer R. Grandis, Sufi M. Thomas
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (13): 4336–4344.
https://doi.org/10.1158/1078-0432.CCR-07-4857
Published: 01 July 2008
View articletitled, Combined Inhibition of PLCγ-1 and c-Src Abrogates Epidermal Growth Factor Receptor–Mediated Head and Neck Squamous Cell Carcinoma Invasion
Open the PDF for Combined Inhibition of PLCγ-1 and c-Src Abrogates Epidermal Growth Factor Receptor–Mediated Head and Neck Squamous Cell Carcinoma Invasion in another window
Journal Articles

Combined Inhibition of c-Src and Epidermal Growth Factor Receptor Abrogates Growth and Invasion of Head and Neck Squamous Cell Carcinoma

Free
Priya Koppikar, Seung-Ho Choi, Ann Marie Egloff, Quan Cai, Shinsuke Suzuki, Maria Freilino, Hiroshi Nozawa, Sufi M. Thomas, William E. Gooding, Jill M. Siegfried, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (13): 4284–4291.
https://doi.org/10.1158/1078-0432.CCR-07-5226
Published: 01 July 2008
View articletitled, Combined Inhibition of c-Src and Epidermal Growth Factor Receptor Abrogates Growth and Invasion of Head and Neck Squamous Cell Carcinoma
Open the PDF for Combined Inhibition of c-Src and Epidermal Growth Factor Receptor Abrogates Growth and Invasion of Head and Neck Squamous Cell Carcinoma in another window
Journal Articles

Selective Inhibition of ADAM Metalloproteases as a Novel Approach for Modulating ErbB Pathways in Cancer

Free
Jordan S. Fridman, Eian Caulder, Michael Hansbury, Xiangdong Liu, Genjie Yang, Qian Wang, Yvonne Lo, Bin-Bing Zhou, Maxwell Pan, Sufi M. Thomas, Jennifer R. Grandis, Jincong Zhuo, Wenqing Yao, Robert C. Newton, Steven M. Friedman, Peggy A. Scherle, Kris Vaddi
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (6): 1892–1902.
https://doi.org/10.1158/1078-0432.CCR-06-2116
Published: 15 March 2007
View articletitled, Selective Inhibition of ADAM Metalloproteases as a Novel Approach for Modulating ErbB Pathways in Cancer
Open the PDF for Selective Inhibition of ADAM Metalloproteases as a Novel Approach for Modulating ErbB Pathways in Cancer in another window
Journal Articles

Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting

Free
John C. Sok, Francesca M. Coppelli, Sufi M. Thomas, Miriam N. Lango, Sichuan Xi, Jennifer L. Hunt, Maria L. Freilino, Michael W. Graner, Carol J. Wikstrand, Darell D. Bigner, William E. Gooding, Frank B. Furnari, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (17): 5064–5073.
https://doi.org/10.1158/1078-0432.CCR-06-0913
Published: 01 September 2006
View articletitled, Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting
Open the PDF for Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting in another window
Journal Articles

Abrogation of Head and Neck Squamous Cell Carcinoma Growth by Epidermal Growth Factor Receptor Ligand Fused to Pseudomonas Exotoxin Transforming Growth Factor α-PE38

Free
Sufi M. Thomas, Qing Zeng, Michael W. Epperly, William E. Gooding, Ira Pastan, Qing Cheng Wang, Joel Greenberger, Jennifer Rubin Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (20): 7079–7087.
https://doi.org/10.1158/1078-0432.CCR-04-0587
Published: 22 October 2004
View articletitled, Abrogation of Head and Neck Squamous Cell Carcinoma Growth by Epidermal Growth Factor Receptor Ligand Fused to Pseudomonas Exotoxin Transforming Growth Factor α-PE38
Open the PDF for Abrogation of Head and Neck Squamous Cell Carcinoma Growth by Epidermal Growth Factor Receptor Ligand Fused to Pseudomonas Exotoxin Transforming Growth Factor α-PE38 in another window